nouvelles
les langues
Live Cam
contact
empreinte
Ulm
Français
fr
Deutsch
de
English
en
nouvelles
les langues
Live Cam
contact
empreinte
Français
fr
Deutsch
de
English
en
EKM WS18 Introduction à la médecine clinique
GTE Développement historique de la médecine
Medizin
Button
Robert Koch Institut
Rote Liste
Pub Med
Dolosys
cardiologie
JAN
26
The environmental exposome in heart failure risk and progression
By:
Omar Hahad
on
JAN
26
Nature Reviews Cardiology, Published online: 26 January 2026; doi:10.1038/s41569-026-01247-1The environmental exposome, which includes pollution, contamination, climate and social determinants of health, is intricately involved in the pathophysiology of heart failure. In this Review, Hahad and colleagues explore the complex relationship between environmental stressors and heart failure, advocating for their inclusion alongside traditional risk factors and highlighting the need for new strategies to address the effects of the exposome on public health.
En savoir plus >>
JAN
23
Residual cardiovascular risk in coronary artery disease: from pathophysiology to established and novel therapies
By:
Mattia Galli
on
JAN
23
Nature Reviews Cardiology, Published online: 23 January 2026; doi:10.1038/s41569-026-01249-zIn this Review, Galli and colleagues discuss the mechanisms and associated biomarkers of traditional and emerging factors responsible for the residual risk of recurrent adverse cardiovascular events in patients with coronary artery disease, with a focus on new pathophysiological insights and the therapeutic implications.
En savoir plus >>
JAN
22
Low-dose IL-2 therapy reduces arterial inflammation in acute coronary syndromes
By:
Irene Fernández-Ruiz
on
JAN
22
Nature Reviews Cardiology, Published online: 22 January 2026; doi:10.1038/s41569-026-01256-0Treatment with low-dose IL-2 increases regulatory T cell numbers and reduces arterial inflammation in patients with an acute coronary syndrome and residual systemic inflammation compared with placebo, according to findings from the IVORY trial.
En savoir plus >>
JAN
22
Molecular damage associated with ageing drives inflammation in cardiovascular disease
By:
Allison B. Herman
on
JAN
22
Nature Reviews Cardiology, Published online: 22 January 2026; doi:10.1038/s41569-026-01253-3In this Review, Ferrucci and colleagues propose that inflammation is a resilience mechanism that resolves molecular and cellular damage driven by environmental stressors. With ageing, however, this protective response can become dysregulated and maladaptive, promoting collateral changes central to the pathophysiology of cardiovascular disease.
En savoir plus >>
JAN
19
The use of β-blockers after myocardial infarction: no doubts remain
By:
Dan Atar
on
JAN
19
Nature Reviews Cardiology, Published online: 19 January 2026; doi:10.1038/s41569-026-01252-4The use of β-blockers after myocardial infarction: no doubts remain
En savoir plus >>
JAN
19
Reply to: ‘The use of β-blockers after myocardial infarction: no doubts remain’
By:
John G. F. Cleland
on
JAN
19
Nature Reviews Cardiology, Published online: 19 January 2026; doi:10.1038/s41569-026-01251-5Reply to: ‘The use of β-blockers after myocardial infarction: no doubts remain’
En savoir plus >>
JAN
14
Procoagulant platelets: linking coagulation and thromboinflammation in cardiovascular disease
By:
Rainer Kaiser
on
JAN
14
Nature Reviews Cardiology, Published online: 14 January 2026; doi:10.1038/s41569-026-01250-6In this Review, Kaiser and Nicolai summarize our understanding of procoagulant platelets, describing the signalling pathways that control platelet procoagulant activation and discussing the role of procoagulant platelets in venous and arterial thrombosis, as well as potential therapeutic approaches to target these platelets in thrombotic and thromboinflammatory disorders, including cardiovascular disease, septic inflammation and immune complex-mediated diseases.
En savoir plus >>
JAN
12
Oral anticoagulant therapy after ablation for atrial fibrillation
By:
Giulio Francesco Romiti
on
JAN
12
Nature Reviews Cardiology, Published online: 12 January 2026; doi:10.1038/s41569-026-01248-0Oral anticoagulants are the cornerstone of stroke risk prevention in patients with atrial fibrillation, regardless of whether sinus rhythm is restored. Evidence from two new randomized trials questions the need for long-term treatment with oral anticoagulants after successful ablation of atrial fibrillation and promises to change clinical practice.
En savoir plus >>
Weitere Beiträge
Oncologie clinique
JAN
23
The quintessential role for CAR T cell therapy in children, adolescents and young adults with cancer
By:
Liora Schultz
on
JAN
23
Nature Reviews Clinical Oncology, Published online: 23 January 2026; doi:10.1038/s41571-025-01115-wThis Review outlines the fundamental role of chimeric antigen receptor (CAR) T cell therapy for children, adolescents and young adults (CAYAs) with relapsed and/or refractory B cell acute lymphoblastic leukaemia, emphasizing the crucial need to further exploit CAR T cells and other immunotherapies to improve survival with broadened access across disease states. Opportunities and challenges for expanding CAR T cell therapy to other haematological and non-haematological malignancies in CAYAs are also discussed.
En savoir plus >>
JAN
22
Diagnosis, risk stratification and management of smouldering multiple myeloma
By:
Saurabh Zanwar
on
JAN
22
Nature Reviews Clinical Oncology, Published online: 22 January 2026; doi:10.1038/s41571-026-01119-0Increased understanding of the biology of smouldering multiple myeloma (SMM) is being leveraged to improve the management of this clinically heterogeneous precursor of MM. This Review describes the current diagnostic work-up, risk stratification and management of SMM, highlighting early intervention approaches for high-risk SMM that might provide the best opportunity to convert MM into a curative disease and discussing persistent challenges in this field.
En savoir plus >>
JAN
19
Author Correction: Advances in the management of localized bladder cancers
By:
Marie-Pier St-Laurent
on
JAN
19
Nature Reviews Clinical Oncology, Published online: 19 January 2026; doi:10.1038/s41571-026-01121-6Author Correction: Advances in the management of localized bladder cancers
En savoir plus >>
JAN
15
MicroRNAs in oncology: a translational perspective in the era of AI
By:
Ancuta Jurj
on
JAN
15
Nature Reviews Clinical Oncology, Published online: 15 January 2026; doi:10.1038/s41571-025-01114-xDespite well-established roles of microRNAs (miRNAs) as tumour suppressors or oncogenes, miRNA-based diagnostics, prognostic tools and treatments have yet to be incorporated into routine oncology practice. In this Review, the authors discuss innovative approaches to address challenges in the clinical translation of miRNA-based diagnostics and treatments by integrating fundamental miRNA biology, multiomics and artificial intelligence-driven analyses.
En savoir plus >>
JAN
07
A guide to cancer screening
By:
Stephen W. Duffy
on
JAN
07
Nature Reviews Clinical Oncology, Published online: 07 January 2026; doi:10.1038/s41571-025-01112-zCancer screening aims to identify either pre-malignant conditions or earlier-stage disease in non-symptomatic individuals. The authors of this Review recapitulate the general principles of cancer screening, discussing the current screening practices for several cancer types as well as advances in cancer detection that might hold promise for screening an increasing number of cancers in the future.
En savoir plus >>
JAN
06
Base-edited CAR7 T cells are safe and efficacious in R/R T-ALL
By:
Diana Romero
on
JAN
06
Nature Reviews Clinical Oncology, Published online: 06 January 2026; doi:10.1038/s41571-025-01118-7Base-edited CAR7 T cells are safe and efficacious in R/R T-ALL
En savoir plus >>
JAN
06
Discovery of predictive biomarkers for cancer therapy through computational approaches
By:
Xin Wang
on
JAN
06
Nature Reviews Clinical Oncology, Published online: 06 January 2026; doi:10.1038/s41571-025-01109-8Treatment selection based on the presence of one or more specific biomarkers has the potential to optimize treatment outcomes; nonetheless, most patients lack a specific biomarker that is predictive of benefit from one or more targeted treatment approaches. In this Review, the authors describe the potential of computational analysis approaches to enable the discovery of more complex predictive biomarkers based on comprehensive analysis of large clinical and preclinical datasets and thus address this unmet need.
En savoir plus >>
JAN
05
Advances in the management of localized bladder cancers
By:
Marie-Pier St-Laurent
on
JAN
05
Nature Reviews Clinical Oncology, Published online: 05 January 2026; doi:10.1038/s41571-025-01104-zThe management of localized bladder cancers is rapidly evolving. In this Review, the authors discuss diagnostic innovations, refinements in surgical approaches and novel intravesical or systemic treatments such as immunotherapies and antibody–drug conjugates, as well as future directions including bladder-sparing approaches for muscle-invasive disease and novel biomarkers for personalized treatment and follow-up.
En savoir plus >>
Weitere Beiträge
endocrinologie
hépatologie
néphrologie
neurologie
JAN
16
The Nottingham consensus on dementia risk reduction policy: recommendations from a modified Delphi process
By:
Harriet Demnitz-King
on
JAN
16
Nature Reviews Neurology, Published online: 16 January 2026; doi:10.1038/s41582-025-01173-9Translation of evidence about dementia risk into effective public health policy is a challenge. In this Consensus Statement, Demnitz-King and colleagues present 56 policy recommendations for dementia prevention, providing policymakers with a foundation for designing and implementing evidence-based dementia prevention strategies, prioritizing clear communication, targeted intervention and sustained research investment.
En savoir plus >>
JAN
09
An updated definition of freezing of gait
By:
Moran Gilat
on
JAN
09
Nature Reviews Neurology, Published online: 09 January 2026; doi:10.1038/s41582-025-01179-3Freezing of gait (FOG) is among the most debilitating symptoms of Parkinson disease. This Consensus Statement from the International Consortium for Freezing of Gait presents new guidelines for the definition and assessment of FOG, with the aim of harmonizing the study and management of the condition.
En savoir plus >>
JAN
02
Genetic insights from Parkinson disease in African and African admixed populations
By:
Mie Rizig
on
JAN
02
Nature Reviews Neurology, Published online: 02 January 2026; doi:10.1038/s41582-025-01177-5Emerging genomic studies across Africa are revealing how decades of population bias have constrained understanding of disease mechanisms. New evidence in Parkinson disease genetics illustrates how overlooking Africa’s vast genetic diversity not only limits scientific insight but also slows the development of medical and biotechnological innovations that are vital for advancing global health.
En savoir plus >>
DEC
12
The global threat of vaccine-preventable neurological diseases
By:
Felicia C. Chow
on
DEC
12
Nature Reviews Neurology, Published online: 12 December 2025; doi:10.1038/s41582-025-01172-wWe are witnessing a worldwide resurgence in vaccine-preventable neurological diseases owing to gaps in vaccination coverage caused by multiple factors, including vaccine hesitancy and geopolitical conflicts. This Review highlights ongoing challenges to controlling vaccine-preventable neurological diseases such as measles, poliomyelitis, Japanese encephalitis and meningitis and considers how collaborative global strategies can facilitate effective immunization policies.
En savoir plus >>
DEC
10
RNA polyadenylation altered by TDP43 loss of function
By:
Ian Fyfe
on
DEC
10
Nature Reviews Neurology, Published online: 10 December 2025; doi:10.1038/s41582-025-01178-4Loss of TDP43 from the nucleus in amyotrophic lateral sclerosis and frontemporal dementia leads to changes in polyadenylation that alter mRNA processing, according to new research.
En savoir plus >>
DEC
08
α-Synuclein signatures mark Parkinson disease subtypes
By:
Heather Wood
on
DEC
08
Nature Reviews Neurology, Published online: 08 December 2025; doi:10.1038/s41582-025-01176-6Recent research indicates that the brain-first and body-first subtypes of Parkinson disease can be distinguished by patterns of cutaneous α-synuclein deposition.
En savoir plus >>
DEC
08
Physical activity could protect against cognitive decline
By:
Heather Wood
on
DEC
08
Nature Reviews Neurology, Published online: 08 December 2025; doi:10.1038/s41582-025-01174-8A new study indicates that physical activity reduces cognitive decline, possibly through attenuation of tau accumulation in the brain.
En savoir plus >>
DEC
08
Targeting lysosomal damage in Duchenne muscular dystrophy
By:
Heather Wood
on
DEC
08
Nature Reviews Neurology, Published online: 08 December 2025; doi:10.1038/s41582-025-01175-7A drug that targets lysosomal damage could boost the effects of gene therapy for Duchenne muscular dystrophy, according to new research.
En savoir plus >>
Weitere Beiträge
rhumatologie
urologie
Partager
Tweet
Partager
Courrier
La version française de ce site est principalement traduite automatiquement par "google translate". En cas de difficultés linguistiques, n'hésitez pas à me contacter.
Share by: